Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. - Wikidata - wikimedia - TriplyDB

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

http://www.wikidata.org/entity/Q36410269

about

Angiotensin type 1 receptor inhibition enhances the extinction of fear memory.Brain inflammation and hypertension: the chicken or the egg?What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.Inflammatory molecular signature associated with infectious agents in psychosis.Commercially available angiotensin II At₂ receptor antibodies are nonspecific.Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model.Activation of central PPAR-γ attenuates angiotensin II-induced hypertension.An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan Neurorestoration after traumatic brain injury through angiotensin II receptor blockage Neuroinflammatory and autonomic mechanisms in diabetes and hypertension.Use of total cerebral blood flow as an imaging biomarker of known cardiovascular risks Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system.Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?Neuroprotective effects of angiotensin receptor blockers.Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions.Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.Hypothalamic and inflammatory basis of hypertension.Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.Unravelling the Lesser Known Facets of Angiotensin II Type 1 Receptor.Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition.The High Blood Pressure-Malaria Protection Hypothesis.Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia.Temporal Changes in Cortical and Hippocampal Expression of Genes Important for Brain Glucose Metabolism Following Controlled Cortical Impact Injury in Mice.Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.Effect of subpressor dose of angiotensin II on pain-related behavior in relation with neuronal injury and activation of satellite glial cells in the rat dorsal root ganglia.Angiotensin Receptor Blockade by Inhibiting Glial Activation Promotes Hippocampal Neurogenesis Via Activation of Wnt/β-Catenin Signaling in Hypertension.Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase.Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress.Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients.The Characterization of AT1 Expression in the Dorsal Root Ganglia After Chronic Constriction Injury.

P2860

Q21710697-A845CF63-A034-4693-8402-217DC2827281 Q26825054-D4637E72-1B90-42F6-962D-FB46053E656D Q27025597-BE8EFD13-7FFB-4FDC-B8E8-6FFC5107DD46 Q28081615-B697C4A4-E946-48C6-A474-87B0FBD0C38E Q30585823-74BC0A4D-C2CA-4585-A91F-EE5F6A82F8CD Q33627982-13497662-C3D9-4108-A2CC-D249F241A796 Q34048637-4C390D58-6832-4162-AFCD-65CCEEF67D44 Q34809342-FB38812A-8B2D-4DDF-84F7-54A3E883E971 Q35562699-2732910D-5220-413A-B40E-C372FF60CD77 Q35841988-EE77C892-1881-4C86-BC88-462FA4AFF922 Q35907609-67810A42-0C97-4029-9D44-7F6CBF1CAAB8 Q36019970-3EE38979-12EB-4826-8402-CB31E11B07A9 Q36148314-19BBF9FE-3A2B-4E0D-A23E-CA07BD1CAFC1 Q36167581-E6DEF48D-4DAC-44C5-8E80-8A3B23BE9F20 Q36515931-258C22CD-A2C8-4EBD-AB46-27E1A307F2FE Q37139426-5F576AEE-73F3-4576-B2A8-F6D81F587583 Q37254592-63BABD29-BFF1-4D6A-8DB2-EF3D252809E2 Q37631143-1C1A009B-1D1A-4F9E-AB94-A5DDA8ADDB1E Q38100285-D09BB2F9-8051-43A9-9169-592A7070E952 Q38191484-36D01733-C1DA-4F8D-A2A3-7B1B0556CBC4 Q38200602-D6E9123F-318C-4B33-A4EC-F926D2B33CAD Q38264237-327738EC-7D80-4F7B-99A8-60149CBE49B8 Q38461657-A741CB10-C1B2-4A0F-84C6-34E8AAED0133 Q38542939-FF79D6C0-FDDF-4033-8106-BEAA37E2371E Q38774292-5FD69A2A-48EF-4B28-9948-C9911577D388 Q38781028-D240F54D-9836-46BD-AB1C-D2A1AA6D5524 Q39022945-7AB435B3-63F2-47A8-AFEB-A3AED704AB7D Q40212788-D3A51555-FE55-4385-9D7C-B59DBE5DE8F8 Q40509426-4C13E7E0-2739-46D5-BF36-3B9412237F53 Q41064217-288E6A2B-9B8A-4986-98FB-FD7A380C13AA Q41684033-3766BE0D-0324-422A-A8DD-C09249ED5FE0 Q42479815-41377AA3-3EED-4BFA-8452-86F63D6A864D Q45708399-F650D942-874C-4812-8841-EC1469729D1D Q46310472-F611B35F-520F-48B1-8AF8-3CBEDF5BBDFA Q46311227-EEBD781D-365F-4368-9D91-12573FC48AF7 Q46792828-2CCFA75F-908B-416A-A9BC-E02924305BA3 Q48103115-62A17885-D591-47B5-B45E-A6DCD936F36F Q48106483-47F5F539-74E1-4207-8901-733AFFAF20C7 Q49015944-724DE6A2-17A2-487C-918B-FC34255517D8 Q51695470-75A26DF3-4FC9-411A-9E94-CD7BF5BC8F43

P2860

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

http://www.wikidata.org/entity/Q36410269

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

@ast

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

@en

type

label

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

@ast

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

@en

prefLabel

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

@ast

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

@en

P1433

Q36410269-72D4FD18-1E70-4796-BAAF-47B76FD04D44

P1476

Q36410269-B2BE9E6C-7C99-49EE-8537-6A0B37973526

P2093

Q36410269-4DD87A84-537A-4D86-9085-D290D962DF18

P2860

Q36410269-014F95B8-24AD-422F-97F2-9858CF42BB35

Q36410269-01726996-4D9B-4BC7-9623-795B535F65BE

Q36410269-028CE9F2-F358-4380-8616-B1F40DA04EE7

Q36410269-03256D6F-F890-4523-91AB-1C78B3722660

Q36410269-03F555B0-7895-4208-B462-9CCB5CFA0DD9

Q36410269-05469778-F383-48B0-815B-856C73E78661

Q36410269-07F33673-A8A5-4BFF-B39F-AB1A0925611F

Q36410269-08E8C40B-6B39-4362-A418-A287BC273758

Q36410269-0B5FFE0E-AE50-4764-A4D2-30E7D7CD090F

Q36410269-0E52071F-1C1E-4F06-91D9-2A19E9023AAA

P304

Q36410269-721CD166-CA92-4759-B871-3D425C6F2102

P31

Q36410269-B94CB9A9-A1F0-477B-B332-33F522DA73FB

P356

Q36410269-62B152E7-60A2-4829-BF72-3B5B8972EFFC

P407

Q36410269-D0B96CCB-FE17-41DD-9D94-6ABA55C78B33

P433

Q36410269-A7DFBDBA-E048-4F12-B634-93E3A49CC1A8

P478

Q36410269-BDB79857-9C7E-4E3F-8952-12C2E753AC4F

P577

Q36410269-1FA70843-D72E-46E6-ABC3-6D06C93E015D

P698

Q36410269-E3624B2E-364E-46CD-AE35-91CA775A124D

P921

Q36410269-6AD12506-D3B8-4384-B9CA-0F3F83AF17C6

P932

Q36410269-5066D99B-55C1-41C5-83DF-AE7CBDBFCB12

P356

P1433

Clinical Science

P1476

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

@en

P2093

Juan M Saavedra

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Role of Infection in the Pathogenesis of Alzheimerʼs Disease

From inflammation to sickness and depression: when the immune system subjugates the brain

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Disruption of the Ang II type 1 receptor promotes longevity in mice

Supramaximal dose of candesartan in proteinuric renal disease

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b

Astrocyte-endothelial interactions at the blood-brain barrier

P304

567-590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CS20120078

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22827472

http://www.w3.org/2001/XMLSchema#string

P921

P932

3501743

http://www.w3.org/2001/XMLSchema#string